Caroline Stephan
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 21, 2022
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.
Journal: Transplantation and cellular therapy
Published: May 26, 2022
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs.
Journal: Nature communications
Published: January 21, 2022
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination.
Journal: Blood
Published: December 13, 2021
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
Journal: Bone marrow transplantation
Published: January 28, 2021
Case Report: Severe Complement-Mediated Thrombotic Microangiopathy in IgG4-Related Disease Secondary to Anti-Factor H IgG4 Autoantibodies.
Journal: Frontiers in immunology
Published: September 10, 2020
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts.
Journal: Transplantation and cellular therapy
Published: May 15, 2020
Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome.
Journal: Bone marrow transplantation
Published: September 19, 2017
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation.
Journal: Leukemia & lymphoma
Published: July 07, 2017
Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.
Journal: Bone marrow transplantation
Published: February 09, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026